Initial digest — CXCR4-TMSB4-axis receipt

what this node claims

Initial digest — CXCR4-TMSB4-axis

AlphaFold v6 prediction landed for **CXCR4-TMSB4-axis** (CXCR4 / Thymosin-β4 axis (TB-500)). UniProt accession: `P61073`. Lane: `recovery`. Mean per-residue pLDDT: **82.26**. _(no notes)_

Open source surface

vertical proof spine

evidence / risk instrument

39%

thin proof

low debt pressure 29%

28%structuredebt

pLDDT pending

55%evidencethin

grade C

0%gatesdebt

0/5 gates

100%riskstrong

0 hard flags

22%exportdebt

no export

33%lineagedebt

incomplete spine

proof completeness

33% missing target, alphafold_metric, candidate, export

01 target
02 fold
03 alphafold metric
04 candidate
05 finding
06 export

Metrics and receipt inputs

confidence: 0.6
evidence refs: 1

AlphaFold metrics visual

Confident backbone model

82.3

352 residues / min 31.7 / max 98.5 / source alphafold db

Very high 57.4% 202 residues / >=90

Confident 21.6% 76 residues / 70-89

Low 8.2% 29 residues / 50-69

Very low 12.8% 45 residues / <50

usable fold context with explicit model-confidence limits

Near-complete coverage / observed 352 of 352 residues.

residues 320-352 / mean 48.4
residues 1-26 / mean 39.48
residues 304-310 / mean 63.5
residues 29-34 / mean 63.78

proof debt register

Visible limits, not hidden cleanup.

29%

Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

high low evidence grade attach graded finding with source-linked evidence

low computational-only status add independent evidence, challenge result, or witness review before strengthening

medium no candidate yet leave visible until a stronger public receipt resolves it

Initial digest — CXCR4-TMSB4-axis